Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Majority of Adults Favor Ban on Powdered Alcohol

June 15, 2015 10:08 am | by University of Michigan | News | Comments

After this year's legalization of powdered alcohol, some states have already banned it—a move that the majority of the public supports, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health. Read more..


FDA Approves Brain Implant to Help Reduce Parkinson's Disease, Tremor Symptoms

June 15, 2015 10:01 am | News | Comments

The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremor, a movement disorder that is one of the most common causes of tremors. Read more...


Target Selling Pharmacy, Clinic Businesses to CVS Health

June 15, 2015 9:47 am | by Tom Murphy, AP Business Writer | News | Comments

Target will sell its pharmacy and clinic businesses to the drugstore chain CVS Health for about $1.9 billion in a deal that combines the resources of two retailers seeking to polish their health care reputations. Read more....


Mini-Breast Grown in Petri Dishes: New Tool for Cancer Research

June 15, 2015 8:48 am | by Helmholtz Zentrum Munchen | News | Comments

To elucidate how aggressive types of breast cancer occur, the researchers first examined the function of normal breast stem cells. Read more...


Axial Spondyloarthritis Treatment Market Value Will Almost Double to $2.9B by 2024

June 15, 2015 8:33 am | by Heather Leach, Ph.D., Immunology Analyst, GlobalData | Articles | Comments

The company’s latest report states that the US will cement its position as the largest of the seven major treatment markets (7MM) for axSpA. Read more...


LDC, J&J Innovation to Collaborate on Acceleration of Academic Drug Discovery Initiatives

June 15, 2015 8:22 am | News | Comments

Both companies will collaborate to identify and accelerate innovative drug candidates for the treatment and prevention of diseases with high unmet medical needs. Read more...


Pfizer Reports Top Line Results from Phase 3 Study of Pristiq

June 15, 2015 8:22 am | News | Comments

The drug was evaluated for the efficacy, safety, and tolerability in pediatric patients ages 7 to 17 with Major Depressive Disorder. Read more...


Poisonous Booze Kills Dozens in Nigeria

June 15, 2015 8:21 am | by Seth Augenstein, Digital Reporter | News | Comments

Homemade gin has killed 68 people in less than two weeks in Nigeria, prompting a government crackdown to stop its distillation, according to reports. Read more...


WHO: MERS Not Spreading Outside S. Korea Hospitals

June 15, 2015 8:21 am | by Kim Tong-Hyung, Associated Press | News | Comments

Overcrowded emergency rooms and hospital wards might have contributed to a wider-than-expected transmission of the virus. Read more...


Scientists Identify a Potential New Treatment for Osteoporosis

June 12, 2015 1:57 pm | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a new therapeutic approach that, while still preliminary, could promote the development of new bone-forming cells in patients suffering from bone loss. Read more...


Arcturus, J&J to Collaborate on RNA Medicines

June 12, 2015 1:50 pm | News | Comments

Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals, Inc. (Janssen). Read more...


Novartis Gains FDA Approval for ITP Treatment

June 12, 2015 12:51 pm | News | Comments

Novartis announced today that the US Food and Drug Administration (FDA) has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition. Read more...


Petri Dish Tumor Test Could Personalize Drug Therapy for Cancer Patients

June 12, 2015 11:56 am | by University of Wisconsin-Madison | News | Comments

In a highly successful, first-of-its-kind endeavor, a multidisciplinary team of University of Wisconsin-Madison researchers has created a "tumor in a dish:" an ex vivo microenvironment that can accurately anticipate a multiple myeloma patient's response to a drug. Read more...


Drug Discovery Spotlight: FDA Recommendation for Praluent, Repatha; Identifying Past Viral Infections

June 12, 2015 11:29 am | by Stephanie Guzowski, Editor | News | Comments

Two new cholesterol-lowering drugs, in a class their own, were FDA recommended this week and now, await approval. And a reasonably priced, new blood test can reveal a lifetime’s worth of viral infections. Read more...


Statins Don’t Harm Memory After All, Suggests Million-Patient Study

June 12, 2015 10:09 am | by Cynthia Fox, Science Editor | Articles | Comments

Statins, popular cholesterol lowering drugs, do not appear to cause short-term memory loss after all, according to a large recent study in JAMA Internal Medicine. The study, which looked at some one million patients, indicated past memory-loss reports may have been hampered by detection bias, as both statin users and users of non-statin lipid lowering drugs (LLDs) reported some memory loss. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.